Innovation SuperNetwork

At Holly Health, we are transforming the way individuals approach mental and physical well-being. Founded in 2020, we’ve developed an AI-powered digital health coach that empowers users to turn their health intentions into clear, actionable steps. Our personalized, compassionate service is designed to fit seamlessly into everyday life, supporting long-term, sustainable health changes. Using proprietary AI systems, Holly Health mimics the guidance of a human health coach, offering support in areas such as weight management, stress reduction, wellness, and sleep. We are proud to be ranked among the top 3 health apps by ORCHA, the world’s leading health app evaluation body, with a score of 89%. Since our international launch in 2021, Holly Health has been on a mission to improve the lives of 5 million people by 2025. We are rolling out partnerships with over 100 primary care practices in the UK, helping healthcare professionals support patients with preventative health measures and ongoing well-being. At Holly Health, we believe that health is not a destination but a journey. By offering tailored, science-backed coaching, we make it easier for people to prioritize their well-being every day. Join us as we revolutionize digital health coaching for the modern world.

Holly Health is a digital platform that translates health intentions into daily actions to support mental and physical wellbeing. The service delivers personalized habit coaching, chronic-condition support, and mental health resources through an AI-powered system designed to emulate a human health coach. It has been recognized by ORCHA as a top health app for weight management, stress reduction, wellness, and sleep. Since its international launch in summer 2021, Holly Health has pursued broad adoption and partnerships with primary care practices in the UK, numbering over 100 to date, with a mission to reach millions of users. The platform operates directly with individuals and through integration into primary care settings to help users sustain healthier behaviours and improve overall wellbeing.

RareCan is a company focused on accelerating research and improving outcomes for patients with rare forms of cancer by developing a direct-to-patient clinical trial platform that creates novel patient and data pipelines powered by proprietary technology, enabling quicker and cheaper access to the patients and data needed for precision medicine trials and supporting the faster development of new therapies while increasing the success rate of rare cancer trials.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.